Moderna | MRNA - درآمد حاصل از بهره

قیمت سهام
50.73
تغییر روزانه
-2.12 -4.01%
ماهیانه
-5.25%
سالیانه
86.37%
Q2 پیش بینی
49.64




درآمد حاصل از بهره تغییر دادن تاریخ
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Celltrion KRW 676.66M 6.85B 2025-06
Dianthus Therapeutics USD 3.66M 255K 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Kangmei Pharma CNY 1.81M 2.5M 2025-06
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Moderna USD 73M 8M 2025-09
Pharma Mar EUR 1.63M 3.17M 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Qiagen NV USD 15.07M 1.21M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Sartorius EUR -31.8M 86.7M 2025-12
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M 2025-06